Contact
DMCA
Privacy
Robuta
https://www.elsevier.es/es-revista-medicina-clinica-2-articulo-effectiveness-safety-alirocumab-evolocumab-for-S0025775324003725
Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with...
Background and aimsThe criteria for the use of proprotein convertase subtilisin/kexin type 9
effectiveness
safety
alirocumab
evolocumab
hypercholesterolemia